Kidney Stones Flashcards

1
Q

___ weather increases stone formation

A

hot

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
2
Q

____% recurrence risk at 5 years

A

50-60

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
3
Q

Immobilization leads to hyper____

A

hypercalciuria

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
4
Q

_____ imaging prior to PCNL

A

Non-con CT

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
5
Q

MUST obtain ____ before intervention to stratify infection risk

A

UA

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
6
Q

Ureteral stones <10mm distally should be offered ____

A

alpha-blockers

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
7
Q

Re-imaging prior to surgery if stone ____ OR would change management

A

moved/passed

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
8
Q

Offer stone treatment if MET is not successful after ____

A

4- weeks

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
9
Q

____ is the procedure with lowest morbidity & complication rate

A

ESWL

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
10
Q

1st line therapy for mid or distal ureteral stones - ____

A

URS

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
11
Q

____ is recommended to treat cystine or uric acid ureteral stones

A

URS

Cystine - not well broken down by ESWL

Uric Acid - radiolucent

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
12
Q

Reasons to not stent

  1. No ____ injury
  2. No ____ stricture
  3. _____ contralateral kidney
  4. ____ AKI
  5. No planned 2nd stage URS
A
  1. No ureteral injury
  2. No ureteral stricture
  3. Normal contralateral kidney
  4. No AKI
  5. No planned 2nd stage URS
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
13
Q

Pre-stenting should ____ be performed

A

NOT

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
14
Q

Meds for stent discomfort

A

alpha-blocker

anti-muscarinics

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
15
Q

With infection the first priority is _____

A

decompression of upper tract with stent vs PCN

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
16
Q

In patients with <20mm of non-lower pole stones, you can offer ___ OR ____

A

ESWL or URS

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
17
Q

Total stone burden >2 cm should be treated with ____

A

PCNL

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
18
Q

For symptomatic, non-obstructing stones, you can off ____

A

stone treatment

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
19
Q

May perform ____ when stone filled kidney has negligible function

A

nephrectomy

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
20
Q

Offer ___ or ___ with symptomatic, <10mm lower pole stones

A

ESWL or URS

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
21
Q

NTs are ____ in uncomplicated PCNLs

A

optional

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
22
Q

Use ___ for irrigation for PCNL & URS

A

normal saline

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
23
Q

May prescribe ____ to facilitate stone passage s/p ESWL

A

alpha-blocker

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
24
Q

Do NOT use ____ with pts who have anatomic or functional obstruction

A

ESWL

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
25
____ stones should be treated regardless of symptoms
Staghorn
26
Children always need metabolic evaluation with a ____
24 hr urine
27
In pediatrics with total stones >20 mm, you can offer ___ or ____ with pre-stenting
PCNL ESWL with pre-stenting *no distinction between lower pole*
28
In pregnant pts with ureteral stones, you can offer ____ to pts who fail observation
URS
29
Safest time for stone surgery in pregnancy is ____ trimester
2nd
30
When fragments are present, should offer ____ treatment to render stone free
endoscopic
31
Abort procedure and obtain culture if ____ urine is encountered
purulent
32
In anti-coagulated pts, ____ is 1st line stone therapy
URS
33
Skin to stone distance >____cm is associated with SWL failure
10
34
BMI >____ may prohibit ESWL
30
35
Treatment for 1.8cm lower pole stone in horseshoe kidney
PCNL
36
With ruptured calyx, you can ____
observe
37
Stones resistant to ESWL
CaOx Monohydrate Brushite Cystine
38
Risk factors for uric acid stone formation
T2DM | Obesity
39
Risk factors for hydroxyapatite stone formation
RTA HyperPTH Medullary sponge kidney Carbonic anhydrase inhibitor
40
Pharmacologic therapy for hypercalciuria
Thiazide diuretic
41
Pharmacologic therapy for hyperuricosuria
Allopurinol *in recurrent Ca++ stone formers*
42
Pharmacologic therapy for hypocitraturia
Potassium Citrate
43
Repeat 24 hr urine s/p ____ of dietary or medical intervention
6 months
44
Incidence of kidney stones peaks in the ___________ decades of life.
Fourth to sixth
45
What is the concentration product?
A mathematical expression of the product of the concentrations of the pure chemical components (ions or molecules) of the salt.
46
What is the thermodynamic solubility product?
The point at which the dissolved and crystalline components are in equilibrium for a specific set of conditions. Addition of further crystals to the saturated solution will cause the crystals to precipitate unless the conditions of the solution, such as pH or temperature, are changed.
47
Citrate: inhibitor MOA
Inhibits calcium oxalate and calcium phosphate stone formation: - Complexes with calcium, thereby reducing the availability of ionic calcium to interact with oxalate or phosphate - Directly inhibits the spontaneous precipitation of calcium oxalate - citrate prevents heterogeneous nucleation of calcium oxalate by monosodium urate
48
Magnesium: inhibitor MOA
Complexation with oxalate, which reduces ionic oxalate concentration and calcium oxalate supersaturation
49
Nephrocalcin: inhibitor MOA
- Strongly inhibits the growth of calcium oxalate monohydrate crystals - Inhibit nucleation and aggregation of calcium oxalate crystals
50
Tamm-Horsfall protein: inhibitor MOA
- MOST ABUNDANT PROTEIN in urine | - Potent inhibitor of calcium oxalate monohydrate crystal aggregation, but not growth
51
Osteopontin/uropontin: inhibitor MOA
Inhibit nucleation, growth, and aggregation of calcium oxalate crystals, as well as to reduce binding of crystals to renal epithelial cells in vitro
52
Bikunin: inhibitor MOA
Strong inhibitor of calcium oxalate crystallization, aggregation, and growth in vitro
53
What is the matrix in renal calculi?
Renal calculi consist of crystalline and noncrystalline components. The noncrystalline component is termed matrix, which typically accounts for about 2.5% of the weight of the stone. Composed of a combination of mucoproteins, proteins, carbohydrates, and urinary inhibitors.
54
What percent of dietary Ca is absorbed in the intestine?
Between 30% and 40% of dietary calcium is absorbed from the intestine, with MOST being absorbed in the small intestine and only approximately 10% absorbed in the colon
55
Most POTENT stimulator of intestinal Ca absorption
CALCITRIOL 1,25(OH)2D3 - Active form of vitamin D Decrease in serum Ca --> PTH secretion --> conversion of 25-hydroxyvitamin D3 to calcitriol --> enhancement of Ca absorption
56
Calcitriol acts on the ____ and ____, in addition to its action in increasing intestinal calcium absorption.
Bone: along with PTH, promotes the recruitment and differentiation of osteoclasts that subsequently mobilize calcium from the bone. Kidney: Calcitriol modulates parathyroid function by inhibiting synthesis of PTH through enhanced vitamin D receptor and calcium- sensing receptor (CaSR) expression in the parathyroid glands --> PTH increases renal Ca reabsorption and enhances phosphate secretion
57
PTH action on the bone and kidneys
PTH: stimulates mobilization of calcium from bone through the action of osteoclasts, further raising serum calcium and phosphorus. Kidneys: enhances renal calcium reabsorption and reduces renal tubular reabsorption of phosphate
58
Primary regulator of renal phosphate handling
Regulation of renal phosphate handling is primarily by way of PTH, which inhibits renal tubular reabsorption of filtered phosphate.
59
Oxalate is absorbed in the _______
Oxalate absorption occurs throughout the intestinal tract, with about half or more occurring in the small intestine and half in the colon.
60
Most potent oxalate-degrading bacterium
Oxalibacter formigenes
61
Most common component of urinary calculi
Calcium: a major constituent of nearly 80% of stones
62
Most common abnormality in calcium stone formers
Hypercalciuria: - Greater than 200 mg of urinary calcium/day after adherence to a 400-mg calcium, 100-mg sodium diet for 1 week - Greater than 4 mg/kg/day or greater than 7 mmol/ day in men and 6 mmol/day in women
63
What are the types of hypercalciuria?
ABSORPTIVE: Increased intestinal absorption of Ca --> transient increase in serm CA --> suppressed PTH --> increased renal filtration of Ca --> hypercalciuria RENAL: Impaired renal tubular reabsorption --> elevated urinary Ca --> secondary hyperparathyroidism (serum Ca levels remain normal) RESORPTIVE: Primary hyperparathyroidism (parathyroid adenoma) --> excess PTH --> excess bone resoprtion --> increase renal calcitriol --> enhanced intestinal absorption of calcium --> elevated serum and urine Ca and reduced Phos levels
64
Malignancy-related hypercalcemia
Tumors in patients with humoral hypercalcemia produce a PTH-related protein (PTHrP). Like PTH, PTHrP increases renal calcium absorption and stimulates osteoblasts
65
Hyperoxaluria
Urinary oxalate greater than 40 mg/day, leads to increased urinary saturation of calcium oxalate and subse- quent promotion of calcium oxalate stones
66
Primary hyperoxaluria
Autosomal recessive inherited disorders in glyoxylate metabolism by which the normal conversion of glyoxylate to glycine is prevented, leading to preferential oxidative conversion of glyoxylate to oxalate, an end product of metabolism
67
Enteric hyperoxaluria
Most common cause of acquired hyperoxaluria Chronic diarrheal states --> fat malabsorption results in saponification of fatty acids with divalent cations such as Ca and Mg --> reduced CaOx complexation --> increased pool of oxalate for reabsorption
68
Dietary hyperoxaluria
Overindulgence in oxalate-rich food: nuts, chocolate, brewed tea, spinach, potatoes, beets, rhubarb Severe Ca restriction --> reduced intestinal binding of oxalate, increased intestinal oxalate absorption
69
Hyperuricosuria
Urinary uric acid >600mg/day Increases levels of monosodium urate --> promote CaOx crystallization through heterogenous nucleation or epitaxial crystal growth Sodium urate: adsorbs inhibitors of crystallization!
70
Hypocitraturia
Urinary citrate <320mg/day Acid-base state = primary determinant of urinary citrate excretion Metabolic acidosis: reduces citrate levels secondary to enhanced renal tubular reabsorption and decreased synthesis of citrate in peritubular cells
71
Causes of hypocitraturia
Pathologic states associated with ACIDOSIS: - Distal RTA - Chronic diarrheal states - Excess animal protein - Diuretics - ACE - Strenuous exercise - lactic acidosis
72
RTA
Metabolic acidosis resulting from defects in renal tubular hydrogen ion secretion or bicarbonate reabsorption
73
Type 1 (distal) RTA
Most common form of RTA , associated with STONE FORMATION Dysfunction of the α-type intercalated cells, which secrete protons into the urine via an apical H+-ATPase --> failure to acidify urine HYPERCALCIURIA HYPOCITRATURIA INC. URINARY pH CALCIUM PHOSPHATE most comon
74
Type 2 (proximal) RTA
Defect in HCO3− reabsorption associated with initial high urine pH that normalizes as plasma HCO3− decreases and the amount of filtered HCO3− falls --> bicarbonaturia --> reduced net acid excretion + metabolic acidosis Stones: UNCOMMON because of normal urinary citrate excretion
75
Type 4 (distal) RTA
Associated with chronic renal damage: usually in interstitial renal disease and diabetic nephropathy. Reduced glomerular filtration --> hyperkalemic hyperchloremic met acidosis Can still generate acidic urine in response to acid challenge
76
Hypomagnesiuria
Magnesium complexes with oxalate and calcium salts, and therefore low magnesium levels result in reduced inhibitory activity. Low urinary magnesium is also associated with decreased urinary citrate levels, which may further contribute to stone formation
77
Uric acid stone formation: LOW or HIGH pH?
LOW urine pH is thought to be a risk factor for uric acid, calcium oxalate, and mixed calcium and uric acid stones. At pH 5, even modest amounts of uric acid exceed uric acid solubility
78
Three main determinants of URIC ACID stone formation
Low urine pH Low urine volume Hyperuricosuria
79
Infection stones are primarily composed of ______ and _____.
Infection stones are composed primarily of magnesium ammonium phosphate hexahydrate (MgNH4PO4 • 6H2O) but may in addition contain calcium phosphate in the form of carbonate apatite (Ca10[PO4]6 • CO3)
80
Struvite stones (MAP) occur only with infection by _____
Urea-splitting bacteria
81
Most common urease-producing pathogens (4)
``` Proteus Klebsiella Pseudomonas Staphylococcus E. coli: only rare species produce urease ```
82
Most common organism associated with infection stones
Proteus mirabilis
83
TRUE or FALSE: Struvite stones are more common in women than men
TRUE. Because infection stones occur most commonly in those prone to frequent urinary tract infections, struvite stones occur more often in women than men by a ratio of 2 : 1
84
Ammonium urate stones
Radiolucent! Patients with chronic diarrhea, inflammatory bowel disease, ileostomy bowel diversions, laxative abuse, recurrent urinary tract infection, and recurrent uric acid stone formation
85
Renal stones in pregnancy
Renal blood flow increases, leading to a 30% to 50% rise in glomerular filtration rate, which subsequently increases the filtered loads of calcium, sodium, and uric acid.